We specialize in economic model development and budget impact analysis
We believe that the best available therapies should be accessible to those who need it. That's why at PeriPharm, with the scientific rigor of academia, we are dedicated to facilitating market access to our clients' innovative solutions.
Founded in 2003, PeriPharm is a Canadian company specializing in pharmacoeconomics and outcomes research. Our mission is to offer high-quality and diversified services to ensure optimal market access. Our dedicated team works closely with our clients to provide services covering all their needs.
As a leader in the field of pharmacoeconomics and outcomes research, PeriPharm has contributed to the success of several market access initiatives. We are distinguished through our:
Our team is comprised of a diverse group of professionals, the majority of which have completed graduate studies in pharmacoeconomics, pharmacoepidemiology / biostatistics and drug development. Our team of dynamic professionals are entirely dedicated to the satisfaction of our clients and, through optimal synergistic collaboration, each contribute to the success of the company.Learn more
As a recognized expert in health economics and outcomes research, Jean has accrued over 30 years of experience within the field. Trained as a pharmacist, Jean went on to complete doctoral studies in pharmacoeconomics and founded PeriPharm in 2003. In addition to his active involvement within PeriPharm, Jean also maintains his positions as a professor within the Faculty of Pharmacy and as an associate researcher within the Faculty of Medicine at the Université de Montréal. As a leader in the field, Jean participates on several advisory committees for major pharmaceutical companies and has acted as a pharmacoeconomics expert on the INESSS scientific committee for more than 10 years. His extensive knowledge of the field combined with his notable expertise represents an undeniable and valuable contribution to each and every project.
After completing a doctoral degree in pharmacoeconomics that was accompanied by several scholarships and honorary mentions, Catherine joined Jean as a partner of PeriPharm in April 2017 after more than 10 years of experience within the company. In addition to teaching pharmacoeconomics and health economics at various institutions, Catherine is also an associate professor at the Université de Montréal where she supervises several graduate students. Recognized for her leadership, analytical skills and team spirit, Catherine is fully committed to managing Peripharm and fulfilling the various mandates entrusted to her, which is essential for the success of the projects.
In order to meet all our clients’ needs and provide a turnkey service, we work closely with companies offering complementary services to ours. We have also developed a vast network of external experts including key opinion leaders working in various therapeutic fields with whom we regularly collaborate in the realization of our projects.